Mumbai 400072, India
+91-90045 60540
info@omnisciencecapital.com

Tag: value investing

Science of Alpha from Safety

DAILY VOICE: Earnings downgrades could happen in COVID affected sectors in upcoming quarter: Dr. Vikas Gupta of OmniScience Capital

Dr. Vikas V Gupta, CEO & Chief Investment Strategist, OmniScience Capital, believes that given the lockdowns, it is likely that earning downgrades could happen in sectors that deal with perishable goods and services. In an interview with Moneycontrol’s Kshitij Anand, Gupta said that investors should look for companies benefiting from life from home theme that includes WFH,…
Read more

Demystifying equities-Understanding the potential risks and returns

Synopsis Let us decide to increase our risk tolerance. Easier said than done. So how do we go about it? The mantra we will use is “Knowledge Overcomes Fear”. The more you know and understand about equities the more risk tolerant you are likely to become over time. Dear HENRYs & other NRIs, a rational…
Read more

Sensex, Nifty still far from pre-COVID levels, but over 180 stocks have achieved the goal

Published in Moneycontrol Indian benchmark indices are at a 6-month high but are still 5 percent away from pre-COVID levels. The first case for COVID in India was registered on January 30. Sensex closed at 40,913 and Nifty50 ended at 12,035 that day. Read more about OmniScience Capital’s views on opportunities in Indian mid and smallcaps…
Read more

Is Mr. Market chasing the SuperNormal Portfolio?

India OmniView July 2020 Market has just begun unlocking the value in the ‘Unique’ SuperNormal portfolio Recently, Scientific Investing strategies have had a high absolute performance and outperformance relative to the benchmarks, as well as to other PMS or mutual fund managers. The performance has been broad-based across market caps and countries (US and India).…
Read more

Top 10 PMSes delivered double-digit returns in June, mid & smallcap schemes flavour of the month

Published in Moneycontrol Despite a series of rating downgrades, a deadly border clash with China and an alarming surge in COVID-19 cases, the market remained resilient in June rising, 7.66 percent on a month-on-month basis. … Asit C Mehta Ace Mulitcap took the third spot, with a month-on-month return of 16.4 percent … Read on…
Read more

Being Proactive Is The Need Of The Hour

Published in Dalal Street Investment Journal Several Indian sectors could benefit from the “Make in India” initiative and in the post-pandemic scenario, India’s Atmanirbhar Bharat initiative and the international initiative to restructure global supply chains will help reduce dependency on China. Read more @ Dalal Street Investment Journa Vol. 35, Issue No. 16

Analysts overestimated corporate earnings in 8 out of last 10 years: Ambit

Published in Mint on 25 Jun 2020 The overestimation was at its worst in FY16 and FY17, resulting in a negative divergence of 24% and 25%, respectively. Two years, FY11 and FY19, also saw underestimation resulting in a positive divergence of 14% and 4%. Analysts in the country overestimated corporate earnings in eight out of…
Read more

A Scientific Investor’s Review Of The SuperNormal Portfolio

Dear Investors: In the previous OmniView we have discussed how the SuperNormal portfolio is created using the Scientific Investing approach. Further, we also provided the portfolio governance process during a time of crisis like the current times. In this OmniView we will introduce you to the key segments comprising the US OmniSupreme portfolio. This is…
Read more

Skechers Can Survive The Lockdowns And Might Be Significantly Undervalued

With $1.37 billion of cash, Skechers can survive for around 8 months to more than a year with zero revenues. Even on a conservative, no-growth basis, Skechers is probably undervalued by more than 25%. Inclusive of growth, the expected total return yield from Skechers could be in the range of 15%-20%. Post-coronavirus world being substantially…
Read more

Reports Of Gap’s Demise Are Highly Exaggerated, And Mr. Market’s Fears Have Mispriced The Stock

GPS management has shown clarity to survive through various possible scenarios of COVID-19 crisis. GPS management has the levers on cash expense management to navigate various scenarios. GPS likely will continue having significant cash flows from online sales, including BOPIS using curbside delivery. GPS is available at significant discounts to its intrinsic value under certain…
Read more